Follow
Mark R Baker
Mark R Baker
Professor of Experimental Neurology
Verified email at ncl.ac.uk
Title
Cited by
Cited by
Year
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study
A Varatharaj, N Thomas, MA Ellul, NWS Davies, TA Pollak, EL Tenorio, ...
The Lancet Psychiatry 7 (10), 875-882, 2020
16292020
A proposal for new diagnostic criteria for ALS
JM Shefner, A Al-Chalabi, MR Baker, LY Cui, M de Carvalho, A Eisen, ...
Clinical Neurophysiology 131 (8), 2020
4722020
Multi-system neurological disease is common in patients with OPA1 mutations
P Yu-Wai-Man, PG Griffiths, GS Gorman, CM Lourenco, AF Wright, ...
Brain 133 (3), 771-786, 2010
4652010
Contributions of descending and ascending pathways to corticomuscular coherence in humans
CL Witham, CN Riddle, MR Baker, SN Baker
The Journal of physiology 589 (15), 3789-3800, 2011
2802011
TDP-43 proteinopathies: a new wave of neurodegenerative diseases
EMJ De Boer, VK Orie, T Williams, MR Baker, HM De Oliveira, ...
Journal of Neurology, Neurosurgery & Psychiatry 92 (1), 86-95, 2021
2762021
Cholinergic dysfunction contributes to gait disturbance in early Parkinson’s disease
L Rochester, AJ Yarnall, MR Baker, RV David, S Lord, B Galna, DJ Burn
Brain 135 (9), 2779-2788, 2012
2512012
The effect of diazepam on motor cortical oscillations and corticomuscular coherence studied in man
MR Baker, SN Baker
The Journal of physiology 546 (3), 931-942, 2003
2212003
Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study
STJ Ray, O Abdel-Mannan, M Sa, C Fuller, GK Wood, K Pysden, M Yoong, ...
The Lancet Child & Adolescent Health 5 (9), 631-641, 2021
1842021
Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance
G Pfeffer, GS Gorman, H Griffin, M Kurzawa-Akanbi, EL Blakely, I Wilson, ...
Brain 137 (5), 1323-1336, 2014
1812014
Beta-band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron disease
KM Fisher, B Zaaimi, TL Williams, SN Baker, MR Baker
Brain 135 (9), 2849-2864, 2012
1572012
Treatment of stiff person syndrome with rituximab
MR Baker, M Das, J Isaacs, PRW Fawcett, D Bates
Journal of Neurology, Neurosurgery & Psychiatry 76 (7), 999-1001, 2005
1302005
Botulinum toxin: an update on pharmacology and newer products in development
S Choudhury, MR Baker, S Chatterjee, H Kumar
Toxins 13 (1), 58, 2021
1272021
The relationship between enhanced reticulospinal outflow and upper limb function in chronic stroke patients
S Choudhury, A Shobhana, R Singh, D Sen, SS Anand, S Shubham, ...
Neurorehabilitation and neural repair 33 (5), 375-383, 2019
832019
Stiff person syndrome
ME Duddy, MR Baker
Immune-Mediated Neuromuscular Diseases 26, 147-165, 2009
742009
Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson's disease?
AJ Yarnall, L Rochester, MR Baker, R David, TK Khoo, GW Duncan, ...
Movement Disorders 28 (9), 1285-1288, 2013
732013
Neurophysiological biomarkers for Lewy body dementias
RA Cromarty, GJ Elder, S Graziadio, M Baker, L Bonanni, M Onofrj, ...
Clinical Neurophysiology 127 (1), 349-359, 2016
682016
Muscle responses to transcranial stimulation in man depend on background oscillatory activity
WK Mitchell, MR Baker, SN Baker
The Journal of physiology 583 (2), 567-579, 2007
652007
Corticospinal activation confounds cerebellar effects of posterior fossa stimuli
KM Fisher, HM Lai, MR Baker, SN Baker
Clinical neurophysiology 120 (12), 2109-2113, 2009
642009
Electroencephalographic markers in dementia
N Malek, MR Baker, C Mann, J Greene
Acta Neurologica Scandinavica 135 (4), 388-393, 2017
622017
Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study
AL Ross Russell, M Hardwick, A Jeyanantham, LM White, S Deb, ...
Brain Communications 3 (3), fcab168, 2021
612021
The system can't perform the operation now. Try again later.
Articles 1–20